covid-19 impact on private company valuations and …
TRANSCRIPT
W E B I N A R
COVID-19 Business Resources Webinar – June 10th, 2020
Business Continuity: COVID-19 Impact on Private Company Valuations and Mergers & Acquisitions
Bobby LaCour, Partner, Aldrich CPAs + Advisors
Brian Andreosky, Senior Business Advisor, Aldrich Capital
Carl Pinkard, Partner, Aldrich Capital
Eliot Peters, Managing Director, RA Capital Advisors
Naomi Derner, Managing Director, Vantage Point Advisors
RA Capital Advisors LLC, Member FINRA and SIPC
MEET YOUR MODERATOR
Bobby LaCourPARTNER, ALDRICH CPAs + ADVISORS
Bobby has over fifteen years of experience in public accounting while serving his
clients in the government, nonprofit, and private middle-market sectors.
He specializes in providing consulting, attest and accounting services, in
addition to an extensive background in internal control and operations analysis.
2
MEET YOUR PRESENTERS
Carl Pinkard, CFP®, CEPAPARTNER, ALDRICH CAPITAL
Since 2002, Carl has specialized in working with high net worth families, business owners and medical practitioners, providing financial planning and consulting services. He also works with pension committees and assists with a number of non-profit organizations.
As a leader of our Private Wealth group, Carl helps shape our comprehensive and integrative service model that provides investment management, financial planning and tax services to our clients in San Diego. He also helps guide business owners to help them maximize the value of their business and is a member of the Exit Planning Institute (EPI). He serves on the board of Champions for Health, formerly San Diego County Medical Society.
3
Brian Andreosky, CEPASENIOR BUSINESS ADVISOR, ALDRICH CAPITAL
Brian joined Aldrich in 2019 and is dedicated to helping business owners transition their companies. In this role, he provides exit planning services to help clients maximize the value of their businesses one to five years before marketing the business for sale and is a member of the Exit Planning Institute (EPI).
MEET YOUR PRESENTERS
Eliot PetersMANAGING DIRECTOR, RA CAPITAL ADVISORS
Eliot is a Managing Director with RA Capital Advisors and brings 20 years of experience as an advisor to his clients and plays a key role in the firm’s strategic direction and execution of client engagements. Eliot has considerable expertise in the design and execution of successful processes for sales, mergers, and recapitalizations of founder-led or privately-held businesses.
4
Naomi DernerMANAGNG DIRECTOR, VANTAGE POINT ADVISORS
Naomi is a Managing Director with VPA and brings over 20 years of experience performing valuations of businesses, securities, and intangible assets, serving angel-, venture-, and private equity-backed start-ups, family-owned and closely-held companies, and publicly-held companies. She has specific valuation expertise in technology, life sciences, food, beverage, cannabis, hospitality, media, and consulting.
DISCUSSION OVERVIEW
• Performance and valuation of public equity markets
• Trends in M&A valuations
• Venture Capital investment
• Private Equity
• Considerations for Business Owners
5
The information provided herein does not, and is not intended to, constitute legal advice; instead, all information, content, and materials available are for general informational purposes only. Readers of this presentation should contact their attorney to obtain advice with respect to any particular legal matter. The information was updated as of June 10, 2020 and we recognize it may change. Please contact your Aldrich Advisor for the most up to date information for your situation.This session is being recorded and may be redistributed or replayed.
RECENT PUBLIC MARKET PERFORMANCE
S&P 500 DJIA NASDAQ
Private company valuations won’t necessarily linearly correlate to public market performance, but public equities are generally a good leading indicator. Does your set of buyers include publicly traded companies?
Source: S&P Capital IQ
3,386
2,237
3,123
2,100
2,300
2,500
2,700
2,900
3,100
3,300
3,500
‐33.9%
‐5.7%
29,348
18,592
27,111
18,000
20,000
22,000
24,000
26,000
28,000
30,000
‐36.7%
‐7.6%
9,817
6,861
9,814
6,500
7,000
7,500
8,000
8,500
9,000
9,500
10,000
‐30.1%
‐0.0%
7
‐23.5%‐21.6%
‐12.0% ‐11.0%‐9.3%
‐8.0%
‐30.0%
‐25.0%
‐20.0%
‐15.0%
‐10.0%
‐5.0%
0.0%
S&P 500 (Index ValueChange in Q1‐20)
Apollo GlobalManagement
KKR Blackstone* Ares CapitalManagement
The Carlyle Group
Portfolio
Mark Do
wn %
IMPACT ON PRIVATE EQUITY VALUES FOR Q1 2020
Public Private Equity firms also experienced decreases in portfolio value, but held up better than public markets
Note(*): Excludes energy, entire portfolio down 21.6%Source: PitchBook, Company press releases and SEC filings
8
PARALLELS TO THE GREAT RECESSION?
S&P 500 DJIA NASDAQ13,265
5,500
6,500
7,500
8,500
9,500
10,500
11,500
12,500
13,500
14,500
‐50.6%
‐36.3%
‐7.5%
2,652
1,100
1,300
1,500
1,700
1,900
2,100
2,300
2,500
2,700
2,900
‐52.2%
‐30.8%‐14.4%
So far, there is limited comparability to the Great Recession, which started slow with modest decline. Markets then saw a sharp decline but recovered from lows prior to the official end of the recession
Source: S&P Capital IQ
1,468
600
700
800
900
1,000
1,100
1,200
1,300
1,400
1,500
1,600
‐53.9%
‐37.4%
‐9.4%
PERFORMANCE WILL BE INCREASINGLY INDUSTRY & COMPANY SPECIFIC
Company value will continue to rely on the three pillars of value: growth profile, margin profile, and risk profile
Source: S&P Capital IQ
6.4%
‐1.6%0.0%
‐5.7%‐9.9%
‐10.8%
‐45.0%
‐35.0%
‐25.0%
‐15.0%
‐5.0%
5.0%
15.0%
Percen
tage Cha
nge fro
m Feb
ruary 19
th
Biotechnology Index U.S. Healthcare Index NASDAQ S&P 500 U.S. Restaurants & Bars Index U.S. Industrials Index
8.4x
14.4x 14.6x16.0x
19.6x
14.7x13.0x
14.8x
12.4x
17.3x
7.3x
12.6x 13.0x14.6x
18.6x
14.0x12.5x
14.7x12.4x
18.6x
0.0x
5.0x
10.0x
15.0x
20.0x
25.0x
Energy Utilities Industrials Consumer Staples IT S&P 500 CommunicationsServices
Healthcare Materials ConsumerDiscretionary
TEV / E
BITD
A
2/19/2020 6/5/2020
IMPACT ON PUBLIC COMPANY VALUATIONS
Valuations of public companies have been reduced, with Healthcare, Consumer Discretionary, and other particular sectors maintaining more value than others
Source: S&P Capital IQ
‐13%
‐13%‐8%
‐5%
‐11% ‐5%‐4%
‐1%
0%
7%
$31.8
$27.4
$0
$5
$10
$15
$20
$25
$30
$35
3/15/2019‐ 5/31/2019
3/15/2020‐ 5/31/2020
Capital Invested (USD
$bn
)
2,249
1,751
0
500
1,000
1,500
2,000
2,500
3/15/2019‐ 5/31/2019
3/15/2020‐ 5/31/2020
Numbe
r of D
eals
DECREASE IN VENTURE FUNDING MARKET
Venture Capital and angel deals completed during the COVID-19 crisis are down 22% by deal volume, but only 14% by total invested capital year-over-year
Deal volume in Q1-20 is down significantly, but appeared normal by capital invested which was skewed by mega-deals over $100 million
Source: PwC / CB Insights MoneyTree, PitchBook
$25.3$29.7
$40.1
$26.9$30.9
$28.6
$23.3$26.4
1,7741,608 1,492
1,5111,650
1,5331,399
1,271
$0
$10
$20
$30
$40
$50
$60
0
200
400
600
800
1,000
1,200
1,400
1,600
1,800
2,000
Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20
Investmen
ts (U
SD $bn
)
Numbe
r of D
eals
Investments ($bn) Number of Deals
‐14%
‐22%
CHANGES IN EARLY STAGE INVESTMENTS
The number of deals between March 15th and May 31st are down substantially year-over-year at the angel/seed stage and early stage, but are up in the late stage
Source: PitchBook
$9.5
$8.0
1,002
706
0
250
500
750
1,000
1,250
$0
$3
$6
$9
$12
$15
3/15/2019‐ 5/31/2019
3/15/2020‐ 5/31/2020
Deal Cou
nt
Med
ian Po
st‐M
oney Valua
tion (USD
$mn)
Angel & Seed
Median Post Valuation Deal Count
$39.4
$46.6
699
483
0
150
300
450
600
750
$0
$15
$30
$45
$60
$75
3/15/2019‐ 5/31/2019
3/15/2020‐ 5/31/2020
Deal Cou
nt
Med
ian Po
st‐M
oney Valua
tion (USD
$mn)
Early Stage Venture
Median Post Valuation Deal Count
$105.2
$481.0
549 558
0
150
300
450
600
750
$0
$150
$300
$450
$600
$750
3/15/2019‐ 5/31/2019
3/15/2020‐ 5/31/2020
Deal Cou
nt
Med
ian Po
st‐M
oney Valua
tion (USD
$mn)
Late Stage Venture
Median Post Valuation Deal Count
VENTURE CAPITAL - FUNDING TERMS
• Key takeaways:
• Fewer deals overall, with biggest impact at earliest stages, and valuations holding so far
• Valuations expected to decline, funding may be difficult to obtain at any valuation
15
WHAT IS HAPPENING TO TRANSACTIONS TODAY
• Transactions are still getting closed
• Timelines are extended as buyers wait to see the full extent of the impact
• Fewer transactions are coming to market
• Healthy businesses should continue with process – delayed start
• More prevalent opportunities for add-on acquisitions or minority investments for PE firms
• Strategic buyers are in the market being cautious buyers
17
9.9x
7.9x8.5x 8.9x 8.9x 9.0x 9.1x 9.4x
10.0x 10.0x9.5x
10.1x
0.0x
2.0x
4.0x
6.0x
8.0x
10.0x
12.0x
2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Med
ian EV
/ EB
ITDA
Multip
le
TRANSACTION MULTIPLES OVER TIME
During the Great Recession, overall multiples contracted by 2.0x EBITDA or ~20% from 2008 to 2009
Geography: North AmericaSource: PitchBook
18
MIDDLE-MARKET TRANSACTION MULTIPLES
Multiples for middle-market transactions (deal sizes $10 million to $250 million) have increased over the last few years, from an average of 6.7x in 2015 to 7.4x through May 2020
Source: GF Data
5.9x 5.8x6.3x 5.9x 6.1x 5.7x
6.6x 6.4x 6.6x 6.9x 7.0x 6.9x7.8x
7.2x
8.2x8.9x
7.4x8.1x
9.0x 8.9x 9.1x 8.8x9.5x 9.6x6.7x 6.7x
7.3x 7.2x 7.2x 7.4x
0.0x
2.0x
4.0x
6.0x
8.0x
10.0x
12.0x
2015 2016 2017 2018 2019 YTD May‐20
TEV / E
BITD
A Multip
le
TEV: $10M ‐ $25M TEV: $25M ‐ $50M TEV: $50M ‐ $100M TEV: $100M ‐ $250M Average: $10M ‐ $250M
19
MIDDLE-MARKET DEBT LEVERAGE
Leverage available for middle-market transactions is in decline, reducing buyers’ ability to fund as large of a portion of a transaction with debt
Note(*): As of May 15, 2020Source: SPP Capital Partners
3.5x3.8x
4.0x3.5x 3.4x
2.9x
0.0x
0.5x
1.0x
1.5x
2.0x
2.5x
3.0x
3.5x
4.0x
4.5x
5.0x
5.5x
Jan‐16 Jan‐17 Jan‐18 Jan‐19 Jan‐20 May‐20*
Debt to
EBITD
A Ra
tio
EBITDA: Up to $10M
4.1x 4.0x4.5x 4.6x 4.6x
4.0x
0.0x
0.5x
1.0x
1.5x
2.0x
2.5x
3.0x
3.5x
4.0x
4.5x
5.0x
5.5x
Jan‐16 Jan‐17 Jan‐18 Jan‐19 Jan‐20 May‐20*
Debt to
EBITD
A Ra
tio
EBITDA: $10M ‐ $20M
4.8x5.0x 5.3x 5.1x 5.3x
4.5x
0.0x
0.5x
1.0x
1.5x
2.0x
2.5x
3.0x
3.5x
4.0x
4.5x
5.0x
5.5x
Jan‐16 Jan‐17 Jan‐18 Jan‐19 Jan‐20 May‐20*
Debt to
EBITD
A Ra
tio
EBITDA: $20M +
20
M&A ACTIVITY AND S&P 500 PERFORMANCE OVER TIME
Historically, M&A activity has closely followed developments in the broader capital markets
Note: S&P 500 Index Value through 05‐15‐2020Sources: IMAA, S&P Capital IQ
“Dot‐com Bubble“M&A Down ~36%
Global Financial CrisisM&A Down ~28% COVID‐19
0
500
1,000
1,500
2,000
2,500
3,000
3,500
4,000
0
500
1,000
1,500
2,000
2,500
3,000
3,500
4,000
2000 2002 2004 2006 2008 2010 2012 2014 2016 2018 2020
Inde
x Value
M&A Vo
lume
Recession Quarterly U.S. M&A Volume (4‐quarter rolling average) S&P 500 Index Value
21
M&A ACTIVITY DECLINED SHARPLY
With uncertainty in the market, M&A activity declined significantly from April & May 2019 to April & May 2020, and a number of high profile transactions were called off
Sources: S&P Capital IQ, WSJ
“Xerox Is Ending Hostile Takeover Bid for HP”“Coronavirus pandemic prompts copier maker to walk
away from challenging merger attempt” ‐WSJ
“L Brands, Sycamore Agree to Scrap Victoria’s Secret Deal”
‐ WSJ
“SoftBank Backs Away From Part of Planned WeWork Bailout”
‐WSJ
22
1,498
715
1,532
706
0
200
400
600
800
1,000
1,200
1,400
1,600
1,800
April 2019 April 2020 May 2019 May 2020
Numbe
r of A
nnou
nced
Tran
sactions in th
e U.S.
$0.6 $0.6 $0.6 $0.7 $0.7 $0.7 $0.8 $1.0 $1.2 $1.5$1.1 $1.2 $1.4 $1.5 $1.6 $1.6 $1.7
$2.0$2.3
$2.6
$1.7 $1.8 $1.9$2.2 $2.2 $2.4
$2.6
$3.1
$3.5
$4.1
$0.0
$1.0
$2.0
$3.0
$4.0
$5.0
2010 2011 2012 2013 2014 2015 2016 2017 2018 2019*
Balance (USD
$tn)
Dry Powder ($tn) Unrealized Value ($tn)
PRIVATE EQUITY FUNDS UNDER MANAGEMENT AND DRY POWDER
The capital available for Private Equity firms to deploy continues to rise faster than it can be deployed
Note(*): As of June 30, 2019Source: Preqin
$3.8tnGDP
Germany
23
PRIVATE EQUITY MIX OF INVESTMENTS OVER TIME
Strategies for Private Equity firms have evolved since 2005 with a major shift toward add-on acquisitions
Source: PitchBook
50% 46% 41% 41% 36% 37% 35% 37% 32% 32% 33% 30% 31% 29% 27%
32% 38% 43% 42%42% 43% 45% 45%
45% 48% 48% 50% 49% 52% 55%
18% 16% 16% 18% 23% 20% 20% 18% 22% 20% 20% 20% 20% 19% 18%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Buyout/LBO Add‐on PE Growth/Expansion
24
PRIVATE EQUITY: THE CURRENT COVID-19 PLAYBOOK FOR NEW INVESTMENTS
Source: Company Websites & Newsletters
More Narrow Criteria…
• Increased focus on end-markets relatively insulated long-term from COVID-19, even if there is a short-term impact
• Reduced appetite for cyclicality
• Limited exposure to hospitality, travel, and other heavily impacted industries
But More Expansive Investment Strategy
• More flexible structure as traditional buyout firms consider non-control deals
• “Structured Equity”
• Expanded debt strategies with low and no amortization loans
• Heavy focus on add-ons for healthy portfolio companies
• Lower EBITDA and size thresholds
• High demand for ways to invest in quality companies as most firms are not distressed investors
25
IN SUMMARY
• Macro factors still point to a positive M&A environment in the medium term
• Leverage is down
• Interest rates remain low
• Low tax rates (for now)
• Quality targets are still scarce
• Active firms want to transact
• Transactions occur in every market
26
STRATEGIC VALUATION STRATEGIES TO DEPLOY IN A DOWN MARKET
• Our clients and their advisors are already optimizing tax strategies that take advantage of a temporarily reduced value environment
• Strategies for consideration:
• Generational gifting – private company ownership/wealth transfers
• Current administration raised lifetime gifting exemption from $5.5 million to $11.2 million in 2017 TCJA (double for couples); expires in 2025
• Any changes to tax laws in coming years likely to be adverse, particularly if administration changes following election
• Equity compensation via IRC 409A – non-cash compensation strategies aimed at retention at a time when companies may have cut cash comp
• Minority owner buy-outs – a good time to clean up the cap table
28
SHOW ME YOUR EBITDAC: LIQUIDITY OPTIONS
FOR PRIVATE COMPANIES
Earnings Before Interest, Taxes, Depreciation, Amortization & Coronavirus (EBITDAC)
• Scenario #1: You are a 68 year old owner who was looking to sell in 2020.
29
SHOW ME YOUR EBITDAC: LIQUIDITY OPTIONS
FOR PRIVATE COMPANIES
Earnings Before Interest, Taxes, Depreciation, Amortization & Coronavirus (EBITDAC)
• Scenario #2: You are nearing retirement and are 3-5 years out from the sale of your company.
30
SHOW ME YOUR EBITDAC: LIQUIDITY OPTIONS
FOR PRIVATE COMPANIES
Earnings Before Interest, Taxes, Depreciation, Amortization & Coronavirus (EBITDAC)
• Scenario #3: You still have a long runway ahead of you but know at some point 10+ years out you would like to sell your company.
31
ACTIONS TO CONSIDER TODAY FOR YOUR BUSINESS
Your
BusinessStrategic
Planning
Successorship
Strong
Financials
Employees &
Culture
Marketing &
Brand
Intellectual
Property
Technology
Insurance
32
Navigating an Advantageous Position for your Business
WE ARE HERE TO HELP
The information provided herein does not, and is not intended to, constitute legal advice; instead, all information, content, and materials available are for general informational purposes only. Readers of this presentation should contact their attorney to obtain advice with respect to any particular legal matter. The information was updated as of June 10, 2020 and we recognize it may change. Please contact your Aldrich Advisor for the most up to date information for your situation.This session is being recorded and may be redistributed or replayed.
34
Brian Andreosky, CEPASENIOR BUSINESS ADVISOR, ALDRICH CAPITAL
Carl Pinkard, CFP®, CEPAPARTNER, ALDRICH CAPITAL
Naomi DernerMANAGING DIRECTOR, VANTAGE POINT ADVISORS
Eliot PetersMANAGING DIRECTOR, RA CAPITAL ADVISORS
Contact Us!
Email: [email protected]
Phone: 877.620.4489
RA Capital Advisors LLC, Member FINRA and SIPC